Abul-Hajj Y J, Morris H P
Cancer Res. 1977 Apr;37(4):1083-7.
The activity of estrogen 16alpha-hydroxylase was measured for nine Morris hepatomas of different growth rates and host livers. Activity was measured in the microsomal fraction of the cell (100,000 X g). In the spectrum of hepatomas studied, 16alpha-hydroxylase activity was significantly decreased in parallel with the increase in hepatoma growth rate. The decrease in enzymic activity ranged from 16 to 19% for the slow-growing tumors (Hepatomas 44, 28A, and 9633), 2 to 9% for the intermediate-growing tumors (Hepatomas 38B, 7795, and 5123A), and 0% for the fast-growing tumors (Hepatomas 7288C, 7777, and 42A). Estrogen 16alpha-hydroxylase activity of the liver of tumor-bearing rats differed from that of liver of healthy animals. There was a decrease in enzymic activity ranging from 66% to 90% of normal control rats. The activity level of the host liver did not correlate with tumor growth rate. Stimulation of 16alpha-hydroxylase with phenobarbital showed a 4-fold increase in activity in normal liver and only a 2- to 3-fold increase in host livers. The slow- and intermediate-growing hepatomas showed a 1.2-to 1.4-fold increase in enzyme activity, and no activity or stimulation in the fast-growing hepatomas was observed.
对9个生长速率不同的莫里斯肝癌及宿主肝脏进行了雌激素16α-羟化酶活性测定。在细胞的微粒体部分(100,000×g)测定活性。在所研究的肝癌范围内,16α-羟化酶活性随肝癌生长速率的增加而显著降低。生长缓慢的肿瘤(肝癌44、28A和9633)酶活性降低幅度为16%至19%,生长中等的肿瘤(肝癌38B、7795和5123A)为2%至9%,生长快速的肿瘤(肝癌7,288C、7777和42A)为0%。荷瘤大鼠肝脏的雌激素16α-羟化酶活性与健康动物肝脏的不同。酶活性降低幅度为正常对照大鼠的66%至90%。宿主肝脏的活性水平与肿瘤生长速率无关。用苯巴比妥刺激16α-羟化酶后,正常肝脏活性增加4倍,而宿主肝脏仅增加2至3倍。生长缓慢和中等的肝癌酶活性增加1.2至1.4倍,而生长快速的肝癌未观察到活性增加或刺激现象。